Table 3. Replication of previously reported SNPs associated with sarcoidosis [9], [11], [25], [27].

CHR	BP(hg 19)	SNP	Gene	Alleles1	African Americans							European Americans			PAll-Meta	Heterogeneity Test
					MAFAA-Disc 2	ORAA-Disc	P AA-Disc	MAFAA-Rep 2	ORAA-Rep	P AA-Rep	PAA-Meta	MAFEA 2	OREA	P EA		Q	I 2 (%)
6	32,363,816	rs2076530	BTNL2	T/C	0.309	0.84	2.50E-01	0.312	0.80	2.46E-02	2.42E-02	0.434	0.70	4.19E-06	1.44E-06	0.324	11.3
6	32,412,480	rs7194	HLA-DRA	A/G	0.424	1.66	8.73E-09	0.445	1.40	3.44E-04	1.40E-11	0.395	1.35	1.26E-04	5.28E-14	0.304	16
6	32,429,643	rs9268853	HLA-DRB5	T/C	0.214	0.72	1.16E-03	0.197	0.86	2.03E-01	7.40E-04	0.331	0.76	9.79E-04	2.39E-06	0.544	0
6	32,574,171	rs615672	HLA-DRB1	C/G	0.449	0.64	1.23E-06	0.438	0.72	5.50E-04	2.60E-09	0.643	0.81	8.00E-03	9.97E-10	2.00E-07	93.5
6	57055354	rs1040461	RAB23	C/T	0.158	1.13	3.24E-02	0.177	1.21	1.18E-01	8.04E-03	0.079	0.89	4.18E-01	1.80E-01	0.257	26.4
10	81,926,702	rs1049550	ANXA11	G/A	0.185	0.68	7.91E-04	0.187	0.88	2.89E-01	8.46E-04	0.409	0.81	8.33E-03	2.30E-05	0.356	3.2

¹Major/minor allele of AAs as the reference;

²Minor allele frequency;

³The odds ratio (OR) was calculated with respect to the minor allele of AAs.